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Previous studies by us (1) and by Anders et al. (2) have demonstrated that the 
amyloid A (AA) protein is derived from the amino terminal region of a larger 
serum precursor known as the SAA protein, which has a mol wt of about 11,000- 
14,000 and exists in serum a higher molecular weight complex with a mol wt 
estimated to be  85,000 (3) or 200,000 (4). Though this complex has not been 
isolated, recombination studies of SAA liberated by Sephadex filtration in 10% 
formic acid with several serum proteins implicate binding to serum albumin and 
self-association in the formation of the complex.  1 
Quantitation of the SAA protein has been accomplished only with antisera to 
the AA protein (5), and levels have therefore had to be expressed as equivalents 
of AA protein. During the isolation of SAA from serum it became apparent that 
the radioimmunoassay underestimated the actual amount of SAA in serum by a 
factor of 10 or more (1). Hence, antisera to the SAA protein were prepared to 
obtain a better means of quantitation and also to study the nature of the SAA 
protein. The present report presents the properties and some of the unusual 
features of these antisera, demonstrates the reason why they cannot be used to 
quantitate SAA in serum, and points to the possibility that similar problems 
may arise in quantitating other proteins that exist in serum as complexes. 
Materials and Methods 
SAA and AA.  SAA from two patients, Cot and Wea, with myeloma and macroglobulinemia 
and high concentrations of the SAA protein were isolated as described (1). AA proteins were the 
same as those used in previous studies (5). 
Antisera.  Four  rabbits were immunized with  SAA in  complete Freund's adjuvant  in  the 
footpads and boosted every 2-4 wk in the back. Two of the rabbits responded in 2 mo, one after 6 
mo, and the fourth failed to produce detectable antibodies before death 8 mo after the start of 
immunization. 
Immunologic Methods.  Double diffusion in agar was done as described by Ouchterlony (6). 
Results 
Three of the rabbits produced antibodies after 2-6 mo of immunization. The 
antisera gave a single sharp precipitin band which showed a reaction of identity 
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FIa.  1.  (a, top) The reaction of two pure SAA proteins (C and W). 0.5 mg/ml against two 
antisera to SAA (1) (7). (b, bottom) The reaction of antiserum to SAA (1) with SAA 1 mg/ml 
mixed with an equal vol of (C) 0.15 M NaC1; (2) HSA, 80 mg/ml; (3) HSA, 40 mg/ml; (4) HSA, 
20 mg/ml; (5) HGG, 80 mg/ml; (6) HGG, 40 mg/ml). Note the shortened precipitin line in 
well C and 5 compared to that in Fig. la. 
with  the  two  SAA  preparations  employed  (Fig.  l a).  They  failed  to  react, 
however,  with four preparations  of AA protein and with sera that  gave good 
precipitin  lines with antisera to the AA protein and therefore contained large 
amounts of SAA protein.  Since in the purification of SAA the proteins had been 
subjected to 10% formic acid,  it seemed possible that this measure could have 
induced some changes in the antigenic determinants.  Treatment of the sera or 
AA proteins  with  10% formic acid followed by neutralization  failed to induce 
reactivity with the antisera to SAA. 
Since  SAA  exists  in  serum  complexed to  itself and  to  serum  albumin, 1 it 
seemed possible that the complex was not reactive with anti-SAA because the 
determinants were masked. To test the possibility, a solution of SAA (1 mg/ml) 
was  mixed  either  with  an  equal  volume  of saline,  human  serum  albumin 
ranging in concentration from 80-0.65 mg/ml or human gamma globulin (HGG) 
(80-10 mg/ml), and tested by double diffusion in agar. As shown in Fig. I b, the 
addition of HGG even at the highest concentration did not diminish or alter the 
precipitin line of SAA. In contrast HSA at concentrations greater than 10 mg/ml 
completely abolished precipitation and in concentrations as low as 1.25 mg/ml it 
diminished  the intensity.  Furthermore,  when the mixture  was allowed to dif- 
fuse from a  well adjacent to pure SAA, it shortened the precipitin line of SAA 
(Figs. 1 a  and b). Similar conclusions can be drawn from immunoelectrophoresis 
analyses in which addition of albumin to SAA abolished its reactivity. EDWARD  C.  FRANKLIN  BRIEF  DEFINITIVE  REPORT  1681 
Discussion 
Three points warrant discussion. Firstly, it would appear that the carboxyl 
terminal region unique to SAA and not shared with AA contains the more 
potent antigenic determinants, since all three responding rabbit antisera failed 
to react with the AA protein.  Previous studies have indicated that AA is a 
weaker antigen than SAA since fewer rabbits responded to it and generally 
required more prolonged immunization before antibodies appeared. 
Secondly, though minor differences in the behavior of certain molecules have 
been noted when the protein is tested alone or complexed to another protein, for 
example free light chains compared to IgG (7), haptoglobin, and haptoglobin- 
hemoglobin complex (8), there is no precedent for the complete elimination of 
antigenic activity of one molecule when bound to another. An analogous situa- 
tion may exist in the case of antibodies to idiotypic determinants of immuno- 
globulins whose reactivity can be largely blocked when the antigen binding site 
has reacted with the corresponding  haptene (9). Since here the antibody appears 
to be directed against a small region of the antigen, it seems possible that the 
behavior of SAA could be due to the fact that the binding site is the same as the 
antigenic determinant(s) or that binding causes a change in conformation which 
blocks access of the antibody to the antigenic region of the molecule. 
Thirdly, this unusual feature precludes the use of these antisera in detecting 
and quantitating SAA in serum, since the concentration of albumin is signifi- 
cantly greater than that needed to block reactivity. Although this degree of 
inhibition was not noted with antisera to the AA protein used in the immunoas- 
say to quantitate SAA, some degree of binding of the AA protein to serum 
proteins has been previously observed by us (10). Hence, these findings may 
explain  why the  radioimmunoassay underestimates the  amount of SAA. in 
serum by a factor ofl0 or more (1) and also the observation of Sipe et al. (11) that 
the  apparent  yield of SAA  increases with  each purification step.  Whether 
similar problems will arise in the future with other molecules that exist in 
serum complexed to carrier proteins remains to be determined and should be 
considered in  developing immunoassays for hormones,  vitamins,  and  other 
molecules that  exist  in  serum as  complexes.  Furthermore, the  presence of 
antibodies in the immunized rabbits would have been missed had pure antigen 
not been used in testing. 
Summary 
Three potent  rabbit  antisera  to  human serum amyloid A  protein  (SAA) 
appear to be directed exclusively to the carboxy terminal region not shared with 
the tissue amyloid A protein. Since binding to albumin completely blocks the 
reaction of these antisera with the antigen,  and since SAA exists in serum 
complexed to albumin, the anti-SAA cannot be used to detect or quantitate this 
serum component. The possibility that similar problems will be encountered 
with  immunoassays for molecules that  exist complexed to  other proteins  is 
discussed. 
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